SCHEMBL28825591

SCHEMBL28825591

CC(c1ccc2ccccc2c1N)C1CNCCO1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 3/20 0.45
SLC6A2 P23975 10/20 0.39
SLC6A4 P31645 10/20 0.39
SLC6A3 Q01959 7/20 0.39
KCNH2 Q12809 2/20 0.39
CYP2D6 P10635 2/20 0.39
MLNR O43193 1/20 0.39
ADRB2 P07550 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
HTR2C P28335 1/20 0.39
OPRK1 P41145 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28227519 0.86 SSTR4 (0.46) SSTR4SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL28048694 0.77 NCF1 (0.41) SSTR4SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL28048808 0.76 TLR8 (0.39) SSTR4SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7408917 0.73 SLC6A2 (0.43) SSTR4SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL28227466 0.72 SSTR4 (0.47) SSTR4SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL4631199 0.72 SLC6A2 (0.57) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL1961849 0.72 SLC6A2 (0.57) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL28228207 0.72 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL28236498 0.70 SLC6A2 (0.41) SSTR4SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL6978722 0.70 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105377851-A BET bromodomain inhibitors and therapeutic methods using these inhibitors UNIV MICHIGAN REGENTS 2016-03-02 CN disclosed